Literature DB >> 35483223

Generation and application of semi-synthetic p-Tau181 calibrator for immunoassay calibration.

Lei Liu1, Yuqi Cai2, Bianca M Lauro2, Angela L Meunier2, Jasmeer Chhatwal2, Dennis J Selkoe2.   

Abstract

Evidence suggests that plasma levels of tau protein phosphorylated at specific residues such as p-T181, p-T217, and p-T231 can be used as biomarkers for Alzheimer's disease (AD) diagnosis and prognosis. Accurate tools to calibrate immunoassays (calibrators) to precisely detect phosphorylated residues on tau protein will provide important gains in reliability and specificity. This study sought to establish a method to generate those accurate calibrators. We generated a semi-synthetic (chimeric) p-Tau181 calibrator by coupling a recombinant tau fragment (residues 1-174) with a synthetic peptide containing a single phosphorylated residue (p-T181) via thioester bond formation. The generation of a semi-synthetic protein containing both the N-terminal region of tau and the pT181 epitope was demonstrated by mobility shift assays using CBB staining and immunoblotting with N-terminal and pT181-specific antibodies. p-Tau 181 assays performed with the novel calibrator on multiple platforms revealed LLoQs as low as 0.14 pg/ml. Our facile and inexpensive method generates a semi-synthetic tau pT181 calibrator suitable for different immunoassay platforms. The same method can easily be adapted to other AD-relevant phospho-epitopes such as pT217 and pT231.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Phosphorylated tau; Plasma biomarker; Tau

Mesh:

Substances:

Year:  2022        PMID: 35483223     DOI: 10.1016/j.bbrc.2022.04.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity.

Authors:  Yi-Chen Hsieh; Joseph Negri; Amy He; Richard V Pearse; Lei Liu; Duc M Duong; Lori B Chibnik; David A Bennett; Nicholas T Seyfried; Tracy L Young-Pearse
Journal:  Mol Neurodegener       Date:  2022-09-21       Impact factor: 18.879

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.